New vaccine trial aims to clear Cancer-Causing HPV
NCT ID NCT06210854
Summary
This study is testing whether a new DNA vaccine called pBI-11 can help the body's immune system clear persistent HPV16 or HPV18 infections in women. These specific HPV types are known to cause most cervical cancers. The trial will enroll 48 women who will receive either the vaccine or a placebo injection, with researchers measuring whether the vaccine helps eliminate the virus from the cervix.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.